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A novel Schiff base ligand (L) has been synthesized using 4-(2-amino ethyl) benzene-1,2-diol (Dopamine) and 
1,4 benzoquinone. Co(II), Ni(II), Cu(II) and Zn(II) complexes with this hexadentate ligand have been synthesized 
with metal:ligand (1:1) stoichiometry. The Schiff base ligand and its metal complexes have been characterized by 
elemental analysis, molar conductance, magnetic susceptibility, infrared and electronic spectra, ESR, NMR, Mass 
spectra, powder X-ray diffraction and SEM studies. Molar conductance showed that all complexes are non-electrolytic in 
nature. The Co(II), Ni(II), Zn(II) complexes are found to be octahedral and distorted octahedral structure for Cu(II) 
complex. Powder X-ray diffraction reveals that Schiff base ligand and its metal complexes are nano-crystalline in nature 
but Co(II) complex is amorphous. Different morphologies of synthesized compounds are identified by SEM images. 
Schiff base ligand and its metal complexes were screened against gram-positive bacteria, gram-negative bacteria and 
one fungus strain. The data show that the ligand and its metal complexes have significant activity. Copper(II) complex 
shows better activity than other complexes. The Schiff base ligand and its copper(II) complex are evaluated for the anti-
inflammatory by HRBC membrane stabilization method. The anti-cancer activity of Schiff base ligand and its copper 
complex was also studied against human breast cancer cell line by MTT assay method. The anti-diabetic activity of Schiff 
base ligand and its copper(II) complex is also studied by alpha-amylase method.
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Anti-cancer 
A dopamine molecule comprises a catechol structure 
(a benzene ring with two hydroxyl side groups) with 
one amine group appended through an ethyl chain. It 
is most usually utilized as an energizer sedate in the 
treatment of severe low blood pressure, slow heart 
rate and cardiac arrest
1
. Dopamine is additionally 
integrated with plants and most animals. In the brain, 
dopamine work as a neurotransmitter—a chemical 




Schiff base ligands and their metal complexes 
have extended massively and include a tremendous 
area of organometallic complexes and different 
aspects of bioinorganic science
3
. Schiff base ligands 
are considered “privileged ligands” because they are 
easily prepared by condensation between carbonyl 
compounds (aldehydes or ketones) and primary 
amines
4
. Schiff base ligands are able to coordinate 
many different metals and can stabilize them in 
different oxidation states
5
. Schiff bases, moreover 
known as imines or azomethines, have increased 
incredible popularity for the most part because of 
their simplicity of synthesis, air stability and 
relatively cheap beginning materials
6
. The presence of 
nitrogen and oxygen donor atoms renders these 
compounds effective and stereospecific as catalysts 
for bond formation, oxidation, reduction, hydrolysis 
and other transformation
7
. Enormous quantities of 
Schiff bases have additionally been appeared to 
exhibit a wide scope of biological activities, antitumor, 




The present work is to prepare a Schiff base ligand 
derived from the condensation of dopamine with 
1, 4 benzoquinone. The study has been extended to 
Co(II), Ni(II), Cu(II) and Zn(II) complexes with the 
prepared ligand. All the prepared complexes have 




C NMR, Mass 
spectra, ESR, UV-visible, in addition to elemental 
analysis, molar conductivity and magnetic susceptibility. 
Morphologies of ligand and its complexes were 
analyzed   by  utilizing  powder XRD  pattern  and SEM. 
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Schiff base ligand and its metal complexes 
were accessed for their antibacterial activity. 
Anti-hemolytic, anti-inflammatory, anti-cancer 
activity and anti-diabetic are also evaluated for 
Schiff base ligand and its copper(II) complex.  
Materials and Methods 
Metal acetate salts were purchased from Sigma 
Aldrich Ltd., and were used without further 
purification. Dopamine and 1, 4 benzoquinone of 
AR grade were purchased from TCI chemicals and the 
solvents used for synthesis and characterization were of 
high-performance liquid chromatography grade.  
Elemental analyses were carried out on EURO 
EA-3000 RS-32. IR spectra was recorded on 8400 FTIR 
Shimadzu spectrometer as KBr discs. UV-visible 
spectra (using DMSO as the solvent) were measured 
on Shimadzu UV-2100 spectrometer. Melting points 
were determined on a Buchi 530 apparatus in 
open capillary tubes. Molar conductance of 10
-3
 M 
solution of the complexes in DMSO was recorded on 
Hanna EC 215 conductivity meter by using 0.01 M 




C NMR spectra of 
the ligand and its complexes in DMSO-d6 were 
recorded on a Bruker Advance II 400 spectrometer 
at room temperature using TMS as an internal 
standard. The ESI mass spectra of ligand and its 
metal complexes were recorded on Q-Tof Mass 
spectrometer. Magnetic susceptibility measurements 
were done in a Sherwood scientific magnetic 
susceptibility balance at room 
temperature. TG-DTA analysis was carried out under 
nitrogen atmosphere using Perkin Elmer Pyres Diamond 
TG/DTA Analyzer. The crystalline size of the 
ligand and its complexes were evaluated with X-ray 
diffraction. The powder X-ray diffraction pattern of 
HQCAAP was recorded on Bruker model D8 X-ray 
diffractometer. Scanning electron surface morphological 
studies were obtained using the JSM-5610 scanning 
electron microscope (SEM). X-Band EPR spectra of 
the copper(II) complex in DMSO was recorded on 
Varian E-4X band spectrometer using DPPH as the 
g-marker at room temperature.
Preparation of Schiff base ligand (L) 
Schiff base ligand was prepared by the addition of 
methanolic solution of 1, 4 benzoquinone (1 mmol) 
drop wise into the methanolic solution of 4-(2-
amino ethyl) benzene-1, 2-diol (2 mmol) taken in a 
round bottom flask at room temperature. The 
mixture was thoroughly mixed on a magnetic stirrer 
for 3 h which was followed by refluxing for 6 h 
resulting in the dark brown colored solid product 
(Scheme 1). The product was filtered, washed several 
times with methanol and finally dried in vacuum 
over anhydrous calcium chloride. 
Preparation of Schiff base complexes (ML) 
A solution of metal acetate salts of methanol taken in 
a round bottom flask was slowly added to the 
solution of Schiff base ligand (L) (1 mmol) in DMSO. 
The solution was then thoroughly mixed and was 
Scheme 1 — Synthesis of Schiff base ligand (L) 
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stirred under reflux for 7 h resulting in the isolation of 
the product. The obtained product was filtered, washed 
several times with methanol finally dried in vacuum 
over anhydrous calcium chloride. The Co(II), Ni(II), 
Cu(II) and Zn(II) metal complexes of Schiff base were 
prepared by above general method. The preparation of 
metal complexes is shown in Scheme 2. 
Results and Discussion 
The physical properties and elemental analysis data 
for the Schiff base ligand (L) and its metal complexes 
(ML) are tabulated in Table 1. The melting point of
the metal complexes are higher than the ligand
because of the increased molecular sizes and the
presence of strong ionic and covalent bonds
9
. The
experimental percentages of C, H and N are in close 
agreement with the theoretical values, indicating the 
formation of the proposed compounds. The complexes 
are slightly soluble in ethanol, methanol, acetone and 
chloroform, completely soluble in DMSO and DMF. 
The molar conductivity of the metal complexes in 
DMSO solution (10
-3
 M) at room temperature was 
measured. The low molar conductance values (Table 1) 




FTIR spectral studies 
The significant infra-red (IR) spectral details 
of Schiff base ligand and its complexes are tabulated 
in Table 2.  The   spectra,  as  shown  in  Fig. 1  provide  
Scheme 2 — Synthesis of Schiff base Metal complexes (ML) M= Co(II), Ni(II) and Zn(II) (n=2, 4) and Cu(II) complex (n=1) 
Table 1 — Analytical data of the Schiff base ligand and its mononuclear metal complexes 
Compounds Mol.Wt. Colour M.P. 
(°C) 
Molar conductance 
(Ω- 1 cm2 mol-1) 
Elemental analysis 
C H N M 
Ligand 450.11 Dark 
Brown 
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valuable information about the functional group 
present in the compounds
11
. The IR spectra of the 
prepared ligand showed a strong band at 1620 cm
-1
 
assigned to the formation of the azomethine (C=N) 
group and it is shifted to a lower frequency in 
the region 1605-1615 cm
-1
 in the complexes
12
. 
Furthermore, the hydroxyl group in ligand is observed 
in 3345 cm
-1
 and its absence in the complexes is due 
to the involvement of the phenol O in bonding to 
the metal ion
13
. The absorption bands in the range 
between 2054-2016 cm
-1
 are assigned to ʋ(C-H) 
stretching frequencies
14
. The appearances of bands at 
Table 2 — IR spectral data analysis of the Schiff base ligand and its mononuclear metal complexes 
Compound Wavenumber (cm-1) 
Hydroxyl group H2O(OH) lattice water Imine M-O M- N
Ligand 3345 --- 1610 --- --- 
Cobalt(II) complex ---- 3408 1627 558 436 
Nickel(II) complex ---- 3393 1613 560 451 
Copper(II) complex ---- 3413 1621 558 498 
Zinc(II) complex ---- 3222 1605 520 463 
Fig. 1 — FT-IR spectra of (a) Schiff base ligand and (b-e) its metal complexes
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3408-3413 cm
-1
 are due to lattice water molecules 
which are further confirmed by the appearance of a 
new band at 823-795 cm
-1
 which is due to ʋ(OH) 
(rocking)
15
. The spectra of the prepared complexes 





) which might be because of the 
formation of the (M-O) and (M-N), respectively
16
. 
NMR Spectral studies (1H and 13C NMR) 
1
H NMR data and assignments of Schiff base ligand 
obtained in d6-DMSO at room temperature with 
tetramethylsilane (TMS) as an internal standard
17
. In 
the spectrum, the peak at 3.48 ppm is (s, -HC=N-CH2-) 
due to the methyl proton of the azomethine group in 
the Schiff base ligand
18
. The aliphatic protons (s, 4H 
aliphatic -CH2-) in the dopamine chain show a single 
peak at 2.86 ppm and the aromatic protons (m, 
8H aromatic -CH=CH-) appear as a multiplet at (6.62-
7.46 ppm)
19
. The -OH proton of the phenolic 
group is observed as a singlet at 9.51 and 9.41 
ppm (m, 4H,-OH)
20
 as given below in Fig. 2. 
13 
C NMR spectrum of the free ligand L shows a 
sharp signal at 154 ppm which may be assigned to 
azomethine carbon
21
. The resonance signals observed in 
the region 115.43-128.44 ppm are assigned to 
carbon atoms of aromatic moieties in the ligand 
framework 
22
. The signals assigned to the chemical 
shift of the methylene group are observed at 
50.49 ppm (-CH2) and 40.15 (-CH2) ppm
23
. The carbon
atom of the -OH phenyl group exhibited a peak at 
145.73 ppm
24
 as shown in Fig. 3. 
Electronic spectra and magnetic moment 
The electronic spectra and magnetic moment of the 
Schiff base ligand and its metal complexes are 
presented in Table 3 and Fig. 4. The electronic spectra 
of the Schiff base ligand (L) revealed two intense 
bands in the region 263 nm (38022 cm
-1
) and 290 nm 
(34482 cm
-1
) which are attributed to π-π* and n-π*, 
respectively
25
. In the electronic spectra of complexes, 
these bands are shifted to the higher frequencies 
indicating that azomethine nitrogen atom is involved 
in coordination to the metal ion 
26
. 
Cobalt (II) complex (CoL) 
The electronic spectrum of Co(II) complexes 
exhibits two bands in the region of 570 nm 
(17543 cm
-1
) and 608 nm (16447 cm
-1












, corresponding to an 
octahedral geometry and band at 428 nm (23364 cm
-1
) 
is due to charge transfer (L-M) and the geometry is 




Nickel(II) complex (NiL) 
Based on the spectrum of Ni(II) complex, d-d 
transition showed two bands in the region 529 nm 
(18903 cm
-1
) and 616 nm (16233 cm
-1
), which 
Table 3 — UV spectral data analysis of the Schiff base ligand and its metal complexes 
Compound Absorption bands (nm) in DMSO µeff (BM) 
Ligand 263, 290 --- 
[CoL] 268, 294, 428, 570, 608 4.31 
[NiL] 268, 303, 498, 529, 616 3.12 
[CuL] 266, 302, 402, 545 1.92 
[ZnL] 268,302,416 Diamagnetic 
Fig. 2 — 1H NMR of Schiff base ligand (L) Fig. 3 — 13 C NMR for Schiff base ligand (L) 
GOMATHI et al.: Co(II), Ni(II), Cu(II) AND Zn(II) COMPLEXES DERIVED FROM 4-(2-AMINO 











respectively. The two bands are consistent with 
an octahedral geometry of the complex and a band at 
498 nm (20080 cm
-1
) is due to charge transfer
29
. 
The octahedral geometry of Ni(II) complex is further 
supported by the magnetic moment value of 3.12 B.M
30
. 
Copper(II) complex (CuL) 
The electronic spectrum of the Cu(II) complex 
exhibits a charge transfer band at 402 nm (24875 cm
-1
) 
and a d-d transition band at 545 nm (18348 cm
-1
) 




T2g transition indicating a 
distorted octahedral geometry. The observed magnetic 
value for Cu(II) complex is 1.92 B.M
31
. 
Zinc(II) complex (ZnL) 
The spectrum of the Zn(II) complex showed a 
high-intensity band at 416 nm (24038 cm
-1
) which is 
due to charge transfer. The absence of absorption 
peaks at the visible region indicates an octahedral 
geometry around Zn(II) ion complex
32
. 
ESR Spectral studies 
The ESR spectrum of the Cu(II) complex affords 
information about the geometry and the nature of the 
coordination sites at the Schiff base and the metal. The X-
band ESR spectrum of the Schiff base copper(II) complex 
at 77 K shows two different g-values indicating the 
magnetic anisotropy in the complex as shown in Fig. 5. 
Fig. 4 — ESR spectra for (a) Schiff base ligand and (b-e) its metal complexes
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orbital. In the present complex, the observed g 
values are g‖>g┴>gav (2.002), which endorse that this 




Mass spectra of ligand and its mononuclear 
complexes are shown in Fig. 6. Schiff base ligand C22 
H22H16N4 shows a molecular ion peak at m/z 452[M+1] 
for its monomeric formulation. The m/z value observed 
at 699 [M+1], 698 [M+1]
+
, 649 [M] and 669[M+1] are 
the molecular ion peak of Co C27H32N2O12, NiC27 
H32N2O12, CuC27H26N2O9, ZnC27H28N2O10 complexes, 
respectively, which indicate the stoichiometry 
composition of complexes
34
.  Fig. 5 — Mass spectra of Schiff base ligand and its metal complexes 
Fig. 6 — X-ray diffraction pattern of the (a) Schiff base ligand and (b-e) its metal complexes
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Powder XRD pattern 
The Powder x-ray diffraction pattern of Schiff 
base ligand and its metal complexes are shown in 
Fig. 7(a-e). The X-ray powder pattern learns about the 
compounds that have been carried out in order to 
decide whether the nature of the sample is crystalline 
or amorphous 
35
. From the observed dxrd patterns, the
crystalline size of the complexes was calculated from 
Scherer’s formula:  
Dxrd =0.9λ/β cosθ 
Where, λ is the wavelength (1.5406 Å), β is the 
full-width half maximum of the characteristic peak 
and θ is the diffraction angle for the hkl plane
36
. The 
calculated average grain size value is found to be 
1.30 nm (L), Ni(II) [2.77 nm], Cu(II) [3.20 nm] and 
Zn(II) [7.95 nm] and Co(II) complex is amorphous. 
SEM analysis 
The SEM micrographs of the Schiff base ligand and 
Co(II), Ni(II), Cu(II) and Zn(II) mixed ligand complexes 
are shown in Fig. 8. The SEM micrograph of ligand 
Fig. 7 — X-ray diffraction pattern of the (a) Schiff base ligand and (b-e) its metal complexes
Fig. 8 — SEM analysis of (a) Schiff base ligand and (b-e) its mononuclear complex
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exhibits spherical structured particles with small grains. 
The micrograph of Co(II), Ni(II) and Cu(II) complexes 
exhibit irregular small grains. The Zn(II) complexes 
showed fringing reef like morphology. 
Antimicrobial activity 
Schiff base ligand and its metal complexes were 
tested for in vitro antibacterial activity against Gram-
positive bacteria viz. Staphylococcus aureus and Gram-
negative bacteria viz. Escherichia coli. The antifungal 
activity was studied against Candida albicans. The MIC 
values of the synthesized compounds were evaluated by 
agar plate disc method. Tetracycline and Fluconazole 
were used as standards. The results of antimicrobial 
evaluation and their MIC are given in Table 4. The 
antimicrobial activity suggested that Schiff base ligand 
and metal  complexes  show  significant efficacy against 
all the bacteria and fungi strains. In vitro activity of 
the ligand is better on complexation with metal ions. 
The enhancement in the effectiveness of complexes 
is clarified based on Overtone’s concept of cell 
permeability and chelation theory
37
. According to these 
theories, in a metal complex, the coordination diminishes 
the polarity of metal ion because of the partially sharing 
of the positive charge 
of the metal with donor atoms of the ligand within the 
chelating system. This could increase the lipophilic 
nature of the central metal chelates and favours its 
permeation through the lipid layer of the microbial 
membranes more effectively thus destroying them more 
fierce
38
. The microbial activity of the complexes may 
not be due to chelation alone but it blends with various 
contributions such as dipole moment, solubility, size, 
redox potential of metal ions, coordinating sites, 
solubility, bond length between metal and ligand, geometry 
of the complexes 
39
. The order of activity for bacterial 
species is found to be Tetracycline > Cu(II) > Zn(II)= 
Ni(II) > Co(II). The order of activity for fungicide is found 
to be Fluconazole > Cu(II) > Ni(II) > Zn(II) > Co(II). 
In vitro anti-inflammatory activity 
The anti-inflammatory activities of the Schiff base 
ligand and its copper(II) complex were examined by 
the HRBCs membrane stabilization method. The 
percentage of inhibition of synthesized compounds 
presented Table 5. Schiff base ligand and its copper(II) 
compounds exhibit minimum efficiency compared to 
standard diclofenac sodium. The percentage inhibition of 
hemolysis increases with the increase in concentration
40
. 
Copper(II) complex showed maximum inhibition of 
69% and the complex stabilized human blood cell 
membrane in a dose-dependent manner
41
.  
In-vitro Cytotoxic activity 
The anticancer activities of Schiff base ligand and 
its copper(II) complex were determined by MTT 
assay on human breast cancer cell line MCF7. The 
absorbance of the samples at 570 nm, at various 
Table 4 — Antibacterial and Antifungal activities of the Schiff base ligand and its metal complexes 
S. No. Sample Sample 
concentration 
(mg/mL) 











2 B 4 5 6 
3 C 6 6 8 
4 D 10 8 9 
5 E 6 6 7 
6 Standard Tetracycline 12 12 Fluconazole 14 
A=Schiff base ligand  B= Co(II) complex 
C=Ni(II) complex  D=Cu(II) complex 
E=Zn(II) complex 
Table 5 — Anti-inflammatory activity of Schiff base ligand and its Copper(II) complex 
Concentration 
(µg/mL) 
% Inhibition of hemolysis 
Standard IC50 values Ligand IC50 values Cu(II) complex IC50 values 
20 56.28 0.592 30.07 60.20 35.33 52.80 
40 60.14 46.61 45.86 
60 67.49 51.12 54.13 
80 72.78 58.64 60.90 
100 78.69 63.15 68.42 
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concentrations (3.125-50 (μg/ml)), the percentage of 
cell inhibition and IC50 values are found and reported 
in Table 6 and Fig. 9. The % cell inhibition and IC50 
values indicated that the copper complex has valuable 
features for potential anticancer agents
42,43
.  
In- vitro antidiabetic activity 
The anti-diabetic activity was examined by the 
Alpha-amylase inhibition assay. Inhibition activity of 
standard drug (Maltose), Schiff base ligand and its 
copper(II) complex against Alpha-amylase is shown in 
Table 7. Copper(II) complex shows more inhibition 
efficiency than Schiff base ligand. 
Conclusions 
A new Schiff base ligand derived from 4-(2-amino 
ethyl) benzene-1,2-diol and 1,4 benzoquinone and its 
Co(II), Ni(II), Cu(II) and Zn(II) metal complexes were 
synthesized and characterized by using elemental and 
spectroscopic analysis. The molar conductance values 
showed non-ionic nature for all the metal complexes. 
Electronic, magnetic, ESR and mass data reveal 
octahedral geometry for Co(II), Ni(II) and Zn(II) 
complexes and distorted octahedral geometry for Cu(II) 
complex. Schiff base ligand acts as hexadentate 
coordinating through two nitrogens of the azomethine 
group and four hydroxyl groups in an N2O4 manner. The 
powder XRD pattern and SEM analysis revealed 
nanocrystalline nature for Schiff base ligand and its 
metal complexes except Co(II) complex which exhibit 
amorphous nature. The Schiff base ligand and its metal 
complexes (a-e) were screened against gram-positive 
(Staphylococcus aureus), gram-negative (Escherichia 
coli) bacteria and one fungus (Candida albicans). From 
the antimicrobial data, it reveals that Cu(II) complex 
exhibits more inhibition compared to Schiff base ligand, 
Co(II), Ni(II) and Zn(II) complexes. The anti-
inflammatory activity of Schiff base ligand and 
copper(II) complex was done by HRBCs stabilization 
method. The concentration plays a vital role in 
increasing the degree of inhibition, the activity increased 
with increasing concentration of the synthesized 
compounds. Copper(II) complex has good inhibition 
activity than Schiff base ligand. In vitro anti-cancer 
studies of copper(II) complex showed safer anticancer 
agent against human breast cancer cell lines. The anti-
diabetic activity of the Schiff base ligand and its 
copper(II) complex was examined by Alpha-amylase 
Fig. 9 — Anti-cancer activities of (a) Control, (b) Schiff base ligand and (c) its Copper(II) complex 
Table 6 — Anticancer effects of Schiff base and its Copper(II) complex in term of % cell inhibition at various concentrations 
Ligand (A) 
Concentration (μg/mL) 




Cell viability % IC50 
(μg/mL) 
3.125 97.53 32.18 3.125 95.65 
24.05 6.25 93.72 6.25 87.85 
12.5 79.48 12.5 76.52 
25 57.62 25 48.00 
50 43.61 50 28.93 
Table 7 — Anti-diabetic effects of Schiff base ligand and its Copper(II) complex 
Compounds Concentration (μg/mL) IC50 (μg/mL) 
10 20 30 40 50 
% of inhibition at 540 nm 
Ligand 23.85 30.05 34.01 45.07 51.16 48.95 
Copper(II) Complex 31.57 38.88 43.17 47.91 56.75 40.75 
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inhibition assay method. Copper(II) complex showed 
good anti-diabetic activity. In view of such a result, the 
anti-diabetic therapeutic approach may reduce the 
postprandial glucose level in blood by the inhibition of 
alpha-amylase enzymes, which can be an important 
strategy in the management of blood glucose which can 
be useful for drug designing. 
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